Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Internship and Residency | 3 | 2023 | 1177 | 1.210 |
Why?
|
| Urinary Catheters | 1 | 2024 | 24 | 0.890 |
Why?
|
| Teaching Rounds | 1 | 2023 | 28 | 0.840 |
Why?
|
| Prostatitis | 1 | 2023 | 13 | 0.840 |
Why?
|
| Congresses as Topic | 1 | 2024 | 172 | 0.830 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2023 | 94 | 0.810 |
Why?
|
| Catheter-Related Infections | 1 | 2024 | 130 | 0.800 |
Why?
|
| Education, Medical, Graduate | 2 | 2023 | 515 | 0.710 |
Why?
|
| Communicable Diseases | 1 | 2023 | 160 | 0.700 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 242 | 0.670 |
Why?
|
| Urinary Tract Infections | 1 | 2024 | 300 | 0.670 |
Why?
|
| Thrombocytopenia | 1 | 2021 | 226 | 0.660 |
Why?
|
| Cyclonic Storms | 2 | 2017 | 75 | 0.650 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 174 | 0.640 |
Why?
|
| Containment of Biohazards | 1 | 2018 | 5 | 0.630 |
Why?
|
| Lassa virus | 1 | 2018 | 21 | 0.620 |
Why?
|
| Lassa Fever | 1 | 2018 | 9 | 0.620 |
Why?
|
| Education, Medical | 1 | 2022 | 287 | 0.620 |
Why?
|
| Contact Tracing | 1 | 2018 | 54 | 0.590 |
Why?
|
| Students, Medical | 1 | 2022 | 356 | 0.580 |
Why?
|
| Travel | 1 | 2018 | 116 | 0.570 |
Why?
|
| Thrombosis | 1 | 2021 | 519 | 0.530 |
Why?
|
| Fumigation | 1 | 2015 | 1 | 0.500 |
Why?
|
| Hydrocarbons, Brominated | 1 | 2015 | 7 | 0.500 |
Why?
|
| Housing | 1 | 2015 | 59 | 0.480 |
Why?
|
| Aging | 1 | 2020 | 1184 | 0.430 |
Why?
|
| Psychometrics | 1 | 2017 | 676 | 0.430 |
Why?
|
| Environmental Exposure | 1 | 2015 | 222 | 0.420 |
Why?
|
| New Jersey | 5 | 2018 | 24 | 0.410 |
Why?
|
| Humans | 24 | 2024 | 124299 | 0.320 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 2887 | 0.290 |
Why?
|
| Cyclin-Dependent Kinase 9 | 2 | 2004 | 30 | 0.280 |
Why?
|
| Curriculum | 2 | 2022 | 723 | 0.280 |
Why?
|
| Tuberculosis | 2 | 2024 | 519 | 0.260 |
Why?
|
| Pandemics | 2 | 2023 | 1102 | 0.240 |
Why?
|
| RNA Polymerase II | 2 | 2004 | 100 | 0.230 |
Why?
|
| Cyclins | 2 | 2004 | 101 | 0.230 |
Why?
|
| Cell Size | 1 | 2004 | 80 | 0.220 |
Why?
|
| Urinary Catheterization | 1 | 2024 | 81 | 0.220 |
Why?
|
| Interferon-gamma Release Tests | 1 | 2024 | 82 | 0.220 |
Why?
|
| Latent Tuberculosis | 1 | 2024 | 74 | 0.220 |
Why?
|
| Consultants | 1 | 2023 | 10 | 0.210 |
Why?
|
| Cardiomegaly | 1 | 2004 | 131 | 0.210 |
Why?
|
| Personal Satisfaction | 1 | 2023 | 102 | 0.200 |
Why?
|
| Infection Control | 1 | 2024 | 159 | 0.200 |
Why?
|
| BK Virus | 1 | 2023 | 59 | 0.200 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2022 | 11 | 0.200 |
Why?
|
| Nephritis, Interstitial | 1 | 2023 | 37 | 0.200 |
Why?
|
| Polyomavirus Infections | 1 | 2023 | 90 | 0.190 |
Why?
|
| Internal Medicine | 1 | 2023 | 149 | 0.190 |
Why?
|
| Teaching | 1 | 2023 | 189 | 0.190 |
Why?
|
| Pneumonia, Pneumococcal | 2 | 2013 | 82 | 0.190 |
Why?
|
| Male | 11 | 2024 | 60962 | 0.180 |
Why?
|
| Shock, Septic | 1 | 2022 | 146 | 0.180 |
Why?
|
| Chronic Disease | 2 | 2023 | 1185 | 0.170 |
Why?
|
| Surveys and Questionnaires | 2 | 2022 | 3722 | 0.170 |
Why?
|
| Aged | 8 | 2024 | 19478 | 0.170 |
Why?
|
| Cancer Care Facilities | 1 | 2019 | 30 | 0.170 |
Why?
|
| Referral and Consultation | 1 | 2023 | 539 | 0.160 |
Why?
|
| Inpatients | 1 | 2023 | 496 | 0.160 |
Why?
|
| Liberia | 1 | 2018 | 8 | 0.160 |
Why?
|
| Murinae | 1 | 2018 | 10 | 0.160 |
Why?
|
| Disease Reservoirs | 1 | 2018 | 35 | 0.160 |
Why?
|
| Diagnostic Errors | 1 | 2022 | 332 | 0.150 |
Why?
|
| Public Health Surveillance | 1 | 2018 | 37 | 0.150 |
Why?
|
| Fatal Outcome | 1 | 2018 | 356 | 0.140 |
Why?
|
| Middle Aged | 7 | 2024 | 26451 | 0.140 |
Why?
|
| Meningitis, Meningococcal | 1 | 2017 | 14 | 0.140 |
Why?
|
| Cognition | 1 | 2022 | 730 | 0.140 |
Why?
|
| Neisseria meningitidis, Serogroup B | 1 | 2017 | 7 | 0.140 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2017 | 52 | 0.140 |
Why?
|
| Kidney Transplantation | 1 | 2023 | 634 | 0.140 |
Why?
|
| Meningococcal Vaccines | 1 | 2017 | 30 | 0.140 |
Why?
|
| Adolescent | 4 | 2020 | 19298 | 0.140 |
Why?
|
| Adult | 6 | 2024 | 29386 | 0.140 |
Why?
|
| Endocarditis, Bacterial | 1 | 2018 | 133 | 0.130 |
Why?
|
| Universities | 1 | 2017 | 126 | 0.130 |
Why?
|
| Vaccination | 1 | 2021 | 953 | 0.130 |
Why?
|
| Young Adult | 3 | 2020 | 8976 | 0.130 |
Why?
|
| Heart Transplantation | 1 | 2023 | 857 | 0.130 |
Why?
|
| Disasters | 1 | 2017 | 101 | 0.130 |
Why?
|
| United States Virgin Islands | 1 | 2015 | 1 | 0.130 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2019 | 378 | 0.130 |
Why?
|
| Clinical Competence | 1 | 2022 | 996 | 0.120 |
Why?
|
| Feces | 1 | 2018 | 717 | 0.120 |
Why?
|
| Cause of Death | 1 | 2017 | 468 | 0.120 |
Why?
|
| Public Health | 1 | 2017 | 260 | 0.120 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 1011 | 0.120 |
Why?
|
| Cluster Analysis | 1 | 2015 | 399 | 0.110 |
Why?
|
| Female | 8 | 2024 | 66235 | 0.110 |
Why?
|
| Macrolides | 1 | 2013 | 29 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 2416 | 0.090 |
Why?
|
| Necrosis | 1 | 2011 | 206 | 0.090 |
Why?
|
| Neoplasms | 1 | 2024 | 2759 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 1598 | 0.080 |
Why?
|
| Streptococcus pneumoniae | 1 | 2011 | 372 | 0.080 |
Why?
|
| Bacteremia | 1 | 2011 | 407 | 0.070 |
Why?
|
| Cyclin T | 2 | 2004 | 34 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 723 | 0.060 |
Why?
|
| Disease Outbreaks | 2 | 2018 | 321 | 0.060 |
Why?
|
| Risk Factors | 2 | 2017 | 10138 | 0.060 |
Why?
|
| Retrospective Studies | 5 | 2024 | 16226 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2020 | 14040 | 0.060 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2004 | 86 | 0.050 |
Why?
|
| Biomechanical Phenomena | 1 | 2004 | 243 | 0.050 |
Why?
|
| Animals | 3 | 2018 | 34145 | 0.050 |
Why?
|
| Child | 1 | 2020 | 24434 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2004 | 1625 | 0.040 |
Why?
|
| Myocardium | 1 | 2004 | 997 | 0.040 |
Why?
|
| Incidence | 2 | 2019 | 3079 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2022 | 492 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 305 | 0.040 |
Why?
|
| Death Certificates | 1 | 2017 | 9 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2022 | 1020 | 0.030 |
Why?
|
| Leukemia | 1 | 2019 | 368 | 0.030 |
Why?
|
| Hematologic Neoplasms | 1 | 2019 | 283 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2017 | 269 | 0.030 |
Why?
|
| Kidney | 1 | 2023 | 1345 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 2017 | 313 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2004 | 2608 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1891 | 0.030 |
Why?
|
| Hospitalization | 1 | 2022 | 1753 | 0.030 |
Why?
|
| Serotyping | 1 | 2011 | 178 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2013 | 196 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2004 | 4535 | 0.020 |
Why?
|
| Heart Failure | 1 | 2004 | 2154 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 1194 | 0.020 |
Why?
|
| Texas | 1 | 2019 | 3580 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2011 | 153 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 859 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2013 | 477 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 6470 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 2019 | 0.020 |
Why?
|
| United States | 1 | 2022 | 10765 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 755 | 0.020 |
Why?
|
| Age Factors | 1 | 2013 | 2801 | 0.020 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2004 | 6 | 0.010 |
Why?
|
| Nuclear Respiratory Factors | 1 | 2004 | 8 | 0.010 |
Why?
|
| NF-E2-Related Factor 1 | 1 | 2004 | 9 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 12288 | 0.010 |
Why?
|
| Lung | 1 | 2011 | 1483 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 2088 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 624 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 1341 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2004 | 807 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 1569 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 622 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 1702 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2004 | 3052 | 0.010 |
Why?
|
| Rats | 1 | 2004 | 3686 | 0.010 |
Why?
|
| Apoptosis | 1 | 2004 | 1787 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 2055 | 0.010 |
Why?
|
| Mice | 1 | 2004 | 17727 | 0.000 |
Why?
|